A clinical discussion on how the long-term findings of the ZILVERPASS study inform decision-making for challenging ...

Lecture: Refractory Angina: Don’t Treat the Coronaries, Put in a Coronary Sinus Reducer Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is ...

A new method for determining whether patients with heart disease need coronary stents or bypass surgery is more effective than the angiogram, which is currently used, according to research from ...

The American Heart Association and American College of Cardiology (AHA/ACC) have introduced a comprehensive list of clinical performance measures intended to target meaningful gaps in care, and that ...

For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, 10-year data from the DANAMI-3-PRIMULTI trial brought greater assurance that complete revascularization ...

Henry Ford Health Interventional cardiologists William O'Neill, M.D., and Khaldoon Alaswad, M.D., took a page out of the medical history books by performing a new coronary bypass procedure replicated ...

AMT Medical Appoints Geert van Gansewinkel as CEO to Lead Company into Next Growth Phase Revolutionizing Coronary Artery Bypass Surgery ...

Ischemic heart disease is the leading cause of disability and premature death worldwide. Chronic coronary syndrome (CCS), previously known as stable angina, is a progressive and chronic disease of the ...

Please provide your email address to receive an email when new articles are posted on . Long-term follow-up from DANAMI-3-PRIMULTI shows reduction in events after complete revascularization vs.